Author: Qibin Liu; Xuemin Fang; Shinichi Tokuno; Ungil Chung; Xianxiang Chen; Xiyong Dai; Xiaoyu Liu; Feng Xu; Bing Wang; Peng Peng
Title: Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool Document date: 2020_4_11
ID: 125o0o7x_23
Snippet: The copyright holder for this preprint . https://doi.org/10.1101/2020.04.06.20056127 doi: medRxiv preprint with known clinical outcomes so far. Significant reductions in T cells are very common in severe COVID-19 patients. Age-dependent deficits in T cell and B cell functions and overproduction of type 2 cytokines may cause inadequate viral replication control and longer pro-inflammatory responses, which may lead to poor prognoses 22 . Lymphopeni.....
Document: The copyright holder for this preprint . https://doi.org/10.1101/2020.04.06.20056127 doi: medRxiv preprint with known clinical outcomes so far. Significant reductions in T cells are very common in severe COVID-19 patients. Age-dependent deficits in T cell and B cell functions and overproduction of type 2 cytokines may cause inadequate viral replication control and longer pro-inflammatory responses, which may lead to poor prognoses 22 . Lymphopenia is a prominent part of SARS-CoV infection and lymphocyte counts may be useful in predicting the severity and clinical outcomes [23] [24] [25] . We know that 2019-nCoV was once called Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-20) [26] [27] .
Search related documents:
Co phrase search for related documents- cell function and clinical outcome severity: 1, 2, 3, 4
- cell function and clinical outcome severity predict: 1, 2
- cell function and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8
- cell function and poor prognosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- cell function and pro inflammatory response: 1
- cell function and replication control: 1, 2, 3, 4, 5, 6, 7, 8
- cell function and SARS cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cell function and SARS cov infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cell function and severe patient: 1, 2, 3, 4
- cell function and significant reduction: 1, 2, 3
- cell function and viral replication control: 1, 2
- clinical outcome and poor prognosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical outcome and pro inflammatory response: 1, 2, 3, 4
- clinical outcome and replication control: 1, 2
- clinical outcome and SARS cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical outcome and SARS cov infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical outcome and severe patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical outcome and significant reduction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical outcome and viral replication control: 1
Co phrase search for related documents, hyperlinks ordered by date